Methotrexate pharmacogenomics

Ann Rheum Dis. 2006 Sep;65(9):1121-3. doi: 10.1136/ard.2006.051789.

Abstract

Observations of clinical effects of methotrexate will help in patient‐management decisions

Publication types

  • Comment
  • Review

MeSH terms

  • Antirheumatic Agents / pharmacology*
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / genetics
  • Humans
  • Methotrexate / pharmacology*
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Polymorphism, Single Nucleotide*

Substances

  • Antirheumatic Agents
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Methotrexate